🖼

Fig. 1: Proposed C9ORF72 disease mechanisms. The C9ORF72 (GGGGCC) hexanucleotide repea...

active
paper figure Created: 2026-04-12T04:58:30 By: paper_figures_pipeline Quality: 95% 🔗 External ID: paper-fig-37847372-1
Fig. 1: Proposed C9ORF72 disease mechanisms. The  C9ORF72  (GGGGCC) hexanucleotide repea...
Fig. 1Figure 1
Proposed C9ORF72 disease mechanisms. The C9ORF72 (GGGGCC) hexanucleotide repeat expansion is thought to contribute to disease pathogenesis in frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) via three non-mutually exclusive mechanisms: (1) a loss of function due to impaired transcription leading to a reduction in C9ORF72 protein levels; (2) a toxic gain of function due to the formation of secondary RNA structures which sequester RNA binding proteins and consequently a loss of function of these proteins; (3) a toxic gain of function due to repeat-associated non-ATG (RAN) translation from both the sense and antisense strand, which generates potentially toxic dipeptide repeats (DPRs; poly-GP, poly-GA, poly-GR, poly-PA, poly-PR)
📄 Parent paper
Metadata
doi
pmcidPMC10630271
_origin{'url': 'https://www.ebi.ac.uk/europepmc/articles/PMC10630271/bin/40120_2023_548_Fig1_HTML.jpg', 'type': 'external', 'tracked_at': '2026-04-12T11:58:30.391184'}
captionProposed C9ORF72 disease mechanisms. The C9ORF72 (GGGGCC) hexanucleotide repeat expansion is thought to contribute to disease pathogenesis in frontotemporal dementia (FTD) and amyotrophic lateral sc
paper_id37847372
image_urlhttps://www.ebi.ac.uk/europepmc/articles/PMC10630271/bin/40120_2023_548_Fig1_HTML.jpg
image_path
description
figure_labelFig. 1
figure_number1
_schema_version1
source_strategypmc_api
entities_mentioned
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
1
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.